Search | IOVS | ARVO Journals

Showing 1 – 20 of 29

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2022

Optogenetics in the clinic: safety and efficacy updates on the phase 1/2 clinical trial PIONEER

Jose Alain Sahel; Isabelle S Audo; Elise Boulanger-Scemama; Chloé Pagot; Angelo Arleo; Joseph N Martel; Simona Degli Esposti; Alexandre Delaux; Jean-Baptiste de Saint Aubert; Caroline de Montleau; Emmanuel Gutman; Jens Duebel; Serge Picaud; Deniz Dalkara; Magali Taiel; Botond Roska

Invest. Ophthalmol. Vis. Sci.. 2022; 63(7):1106. doi:

ARVO Annual Meeting Abstract June 2021

Optogenetic GS030 Therapy in Subjects with Retinitis Pigmentosa: Safety and Tolerability Up to Two Years After Treatment Administration in the Phase 1/2a PIONEER Study

Joseph N Martel; Elise Boulanger-Scemama; Simona Degli Esposti; Francesco Galluppi; Laure Blouin; Magali Taiel; Jose Alain Sahel

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):3236. doi:

ARVO Annual Meeting Abstract June 2020

Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness

Philipp Mueller; Tim Treis; Maximilian Pfau; Simona Degli Esposti; Abdulrahman Alsaedi; Peter Maloca; Konstantinos Balaskas; Andrew Webster; Catherine A Egan; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1057. doi:

ARVO Annual Meeting Abstract June 2020

Comparison of white light and scanning laser ophthalmoscopy ultra-widefield pseudocolor reflectance images in foveal hypoplasia

Simona Degli Esposti; Mohamed Rashad; Matt Robertson; Vivi Riga; Navjit Singh; Mariya Moosajee; Michel Michaelides; Andrew R. Webster; Omar A Mahroo

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):5304. doi:

ARVO Annual Meeting Abstract June 2020

Optogenetics in the Clinic: PIONEER, a Phase 1/2a Gene Therapy Program for Non-Syndromic Retinitis Pigmentosa

Joseph Martel; Simona Degli Esposti; Elise Boulanger-Scemama; Francesco Galluppi; Elodie Vernadal; David Gray; Magali Taiel; Laure Blouin; Jose Alain Sahel

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4491. doi:

Low Vision September 2019

Binocular Inhibition of Reading in Macular Telangiectasia Type 2

PDF

Simone Tzaridis; Philipp Herrmann; Peter Charbel Issa; Simona Degli Esposti; Siegfried K Wagner; Marcus Fruttiger; Catherine Egan; Gary Rubin; Frank G. Holz; Tjebo F. C. Heeren
TAGS: eye, reading (activity), reading speed, scotoma, telangiectasis
Invest. Ophthalmol. Vis. Sci.. 2019; 60(12):3835-3841. doi: https://doi.org/10.1167/iovs.18-26414

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

Individualizing therapy for neovascular age-related macular degeneration with aflibercept (the VITAL study): A two year prospective, interventional single-centre trial

Simona Degli Esposti; Maria K Gemenetzi; Maria Eleftheriadou; Hari Jayaram; Bishwanath Pal; Niaz Islam; Peter Addison; Robin Hamilton; Praveen Patel

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):85. doi:

ARVO Annual Meeting Abstract July 2019

A Retrospective Study of Real World Data for stable wet AMD treatment with aflibercept

Maria K Gemenetzi; Praveen Patel; Shweta Anand; Marko Lukic; Simona Degli Esposti; Pearse Andrew Keane; Ella Preston; Robin Hamilton

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):1162. doi:

ARVO Annual Meeting Abstract July 2019

Reading with macular telangiectasia type 2 – a case of binocular confusion.

Tjebo Heeren; Simone Tzaridis; Catherine A Egan; Frank G. Holz; Peter Charbel Issa; Simona Degli Esposti; Philipp Herrmann; Siegfried Karl Wagner; Marcus Fruttiger; Gary S Rubin

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4997. doi:

ARVO Annual Meeting Abstract July 2019

Awareness of olfactory impairment in a cohort of patients with CNGB1 -associated retinitis pigmentosa

Farid Afshar; Gavin Arno; Rola Ba-Abbad; Simona Degli Esposti; Michel Michaelides; Andrew Webster; Omar Mahroo

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):5423. doi:

ARVO Annual Meeting Abstract July 2018

Longitudinal Assessment Of Reading Test Performance In Patients With Type 2 Macular Telangiectasia (MacTel)

Simona Degli Esposti; Sarah Sirrell; Tjebo FC Heeren; Catherine Egan; Gary S Rubin

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1262. doi:

ARVO Annual Meeting Abstract June 2017

Exploration of the phenomenon of regression to the mean in visual acuity measurements in patients with age-related macular degeneration

Simona Degli Esposti; Omar Abdul Rahman Mahroo; Praveen J Patel; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4696. doi:

ARVO Annual Meeting Abstract June 2017

Electrophysiological Characterization of Macular Telangiectasia Type 2 (MacTel)

Mali Okada; Anthony G Robson; Catherine A Egan; Ferenc Sallo; Simona Degli Esposti; Tjebo FC Heeren; Graham E Holder

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4886. doi:

ARVO Annual Meeting Abstract June 2017

Optical coherence tomography angiography in treated neovascular age related macular degeneration

Maria K Gemenetzi; Maria Eleftheriadou; Adam Dubis; Simona Degli Esposti; Zaria Ali; Daren Hanumunthadu; Konstantinos Balaskas; Praveen J Patel

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):46. doi:

ARVO Annual Meeting Abstract September 2016

Atrophy progression on autofluorescence in patients with Maternally Inherited Diabetes and Deafness (MIDD)

Simona Degli Esposti; Marketa Cilkova; Rengin Aslihan Kurt; Pearse A Keane; Dawn Sim; Catherine A Egan; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):1704. doi:

ARVO Annual Meeting Abstract September 2016

Subretinal fluid in Macular telangiectasia type 2 without apparent choroidal neovascularization

Hemal Mehta; Simona Degli Esposti; Catherine A Egan; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4443. doi:

ARVO Annual Meeting Abstract September 2016

Classification of choroidal nevi using swep-source optical coherence tomography and infrared reflectance imaging at different wavelengths

Clara Vazquez-Alfageme; Vasilios Papastefanou; Simona Degli Esposti; Monica Clemo; Praveen J Patel; Mandeep S Sagoo

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5879. doi:

ARVO Annual Meeting Abstract June 2015

An exploratory study of ranibizumab for treatment of quiescent uveitic patients with refractory cystoid macular oedema (The LIMO Study)

Simona Degli Esposti; Ahmed Samy; Oliver Comyn; Gary S Rubin; Ana Quartilho; Wen Xing; Catey Bunce; Richard W J Lee; Narciss Okhravi; Michel Michaelides

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):6165. doi:

ARVO Annual Meeting Abstract April 2014

High-Resolution Imaging To Probe Retinal Integrity In RPGR Associated Rod-Cone Dystrophy

Simona Degli Esposti; Rola Ba-Abbad; Adam Pack; Jonathan Aboshiha; Yusufu N B Sulai; Alfredo Dubra; Andrew Webster; Adam M Dubis; Joseph Carroll; Michel Michaelides

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):254. doi:

ARVO Annual Meeting Abstract June 2013

Severity And Progression Of Diabetic Retinopathy In Type 2 Macular Telangiectasia (MacTel)

Simona Degli Esposti; Tunde Peto; Irene Leung; Ferenc Sallo; Catherine Egan; MacTel Study Group

Invest. Ophthalmol. Vis. Sci.. 2013; 54(15):1531. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Optogenetics in the clinic: safety and efficacy updates on the phase 1/2 clinical trial PIONEER

Optogenetic GS030 Therapy in Subjects with Retinitis Pigmentosa: Safety and Tolerability Up to Two Years After Treatment Administration in the Phase 1/2a PIONEER Study

Progression of Retinopathy Secondary to Maternally Inherited Diabetes and Deafness

Comparison of white light and scanning laser ophthalmoscopy ultra-widefield pseudocolor reflectance images in foveal hypoplasia

Optogenetics in the Clinic: PIONEER, a Phase 1/2a Gene Therapy Program for Non-Syndromic Retinitis Pigmentosa

Binocular Inhibition of Reading in Macular Telangiectasia Type 2

Individualizing therapy for neovascular age-related macular degeneration with aflibercept (the VITAL study): A two year prospective, interventional single-centre trial

A Retrospective Study of Real World Data for stable wet AMD treatment with aflibercept

Reading with macular telangiectasia type 2 – a case of binocular confusion.

Awareness of olfactory impairment in a cohort of patients with CNGB1 -associated retinitis pigmentosa

Longitudinal Assessment Of Reading Test Performance In Patients With Type 2 Macular Telangiectasia (MacTel)

Exploration of the phenomenon of regression to the mean in visual acuity measurements in patients with age-related macular degeneration

Electrophysiological Characterization of Macular Telangiectasia Type 2 (MacTel)

Optical coherence tomography angiography in treated neovascular age related macular degeneration

Atrophy progression on autofluorescence in patients with Maternally Inherited Diabetes and Deafness (MIDD)

Subretinal fluid in Macular telangiectasia type 2 without apparent choroidal neovascularization

Classification of choroidal nevi using swep-source optical coherence tomography and infrared reflectance imaging at different wavelengths

An exploratory study of ranibizumab for treatment of quiescent uveitic patients with refractory cystoid macular oedema (The LIMO Study)

High-Resolution Imaging To Probe Retinal Integrity In RPGR Associated Rod-Cone Dystrophy

Severity And Progression Of Diabetic Retinopathy In Type 2 Macular Telangiectasia (MacTel)

To View More...

You must be signed into an individual account to use this feature.